SCHEMBL7215840

SCHEMBL7215840

CCCOc1ccccc1COc1ccc2c(c1)C=C(C(=O)O)CCS2(=O)=O

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 3/20 0.37
PARP14 Q460N5 1/20 0.35
PARP10 Q53GL7 1/20 0.35
KMT2A Q03164 1/20 0.34
ALOX5 P09917 2/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
RXRA P19793 1/20 0.33
PPARG P37231 3/20 0.33
PPARA Q07869 2/20 0.33
BCHE P06276 2/20 0.33
ACHE P22303 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
PTGES O14684 1/20 0.32
SLC26A4 O43511 1/20 0.32
FFAR1 O14842 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7216783 0.95 PPARD (0.35) PPARDPARP14PARP10KMT2AALOX5
SCHEMBL7217018 0.92 PARP14 (0.36) PARP14PARP10ALOX5PTGDR2L3MBTL1
SCHEMBL7218231 0.92 MAPT (0.34) PPARDPARP14PARP10KMT2AALOX5
SCHEMBL7216417 0.92 PPARD (0.42) PPARDKMT2AALOX5PPARGPPARA
SCHEMBL7218190 0.91 PPARD (0.43) PPARDKMT2AALOX5PPARGPPARA
SCHEMBL7216335 0.89 PARP10 (0.45) PARP14PARP10KMT2AL3MBTL1KDM4E
SCHEMBL7222714 0.86 FFAR4 (0.32) PTGDR2FFAR1
SCHEMBL7218151 0.86 PPARD (0.34) PPARDPARP14PARP10KMT2AL3MBTL1
SCHEMBL7216554 0.84 HRH3 (0.43) KMT2AALOX5RXRAL3MBTL1
SCHEMBL7218103 0.83 NR4A2 (0.49) KMT2AALOX5SLC26A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed